PHARMACOKINETICS OF SUBCUTANEOUS INFLIXIMAB INDUCTION AND MAINTENANCE IN MODERATE-TO-SEVERELY ACTIVE CROHN'S DISEASE PATIENTS: WEIGHT MATTERS

被引：0
|
作者：
Anjie, Suzanne I.
Mathot, Ron
Gecse, Krisztina
D'Haens, Geert
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1811
引用
收藏
页码：S824 / S825
页数：2
相关论文
共 50 条
  • [11] Tofacitinib Pharmacokinetics and Durability of Drug Exposure in Moderate to Severe Crohn's Disease Patients in Phase 2 Induction and Maintenance Studies
    Mukherjee, Arnab
    Deng, Chenhui
    Xie, Rujia
    Martin, Steven W.
    Chan, Gary
    Moscariello, Michele
    Niezychowski, Wojciech
    Maller, Eric
    GASTROENTEROLOGY, 2016, 150 (04) : S774 - S774
  • [12] Subcutaneous infliximab in Crohn's disease patients with previous immunogenic failure of intravenous infliximab
    Husman, Julia
    Cerna, Karin
    Matthes, Katja
    Gilger, Maximilian
    Arsova, Maia
    Schmidt, Alexandra
    Winzer, Nadia
    Brosch, Anna-Magdalena
    Brinkmann, Franz
    Hampe, Jochen
    Zeissig, Sebastian
    Lukas, Milan
    Schmelz, Renate
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2024, 39 (01)
  • [13] Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
    Cerna, Karin
    Duricova, Dana
    Lukas, Martin
    Kolar, Martin
    Machkova, Nadezda
    Hruba, Veronika
    Mitrova, Katarina
    Kubickova, Kristyna
    Kostrejova, Marta
    Jirsa, Jakub
    Kastylova, Kristyna
    Peterka, Stepan
    Vojtechova, Gabriela
    Lukas, Milan
    CROHNS & COLITIS 360, 2023, 5 (04)
  • [14] Review article: efficacy of infliximab in Crohn's disease - induction and maintenance of remission
    Rutgeerts, PJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 : 9 - 15
  • [15] Prospective study of phArmaCokinetics of InFliximab during induction in patients with Crohn's disease and ulcerative colitis (PACIFIC)
    Liefferinckx, C.
    Bossuyt, P.
    Thomas, D.
    Rahier, J. F.
    Louis, E.
    Baert, F.
    Dewint, P.
    Pouillon, L.
    Lambrecht, G.
    Vermeire, S.
    Franchimont, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S343 - S344
  • [16] PROSPECTIVE STUDY OF PHARMACOKINETICS OF INFLIXIMAB DURING INDUCTION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS (PACIFIC)
    Liefferinckx, Claire
    Bossuyt, Peter
    Thomas, Debby
    Rahier, Jean-Francois
    Louis, Edouard
    Baert, Filip J.
    Dewint, Pieter
    Pouillon, Lieven
    Lambrecht, Guy
    Vermeire, Severine
    Franchimont, Denis
    GASTROENTEROLOGY, 2020, 158 (06) : S456 - S456
  • [17] Efficacy of Induction upadacitinib Therapy in Chinese Patients with Moderately to Severely Active Crohn's Disease
    Chen, M.
    Gao, X.
    Cao, Q.
    Zhang, X.
    Chen, Y.
    Hou, X.
    Zhong, J.
    Sun, Y.
    Phaleng, X.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1213 - I1213
  • [18] Tofacitinib pharmacokinetics and durability of drug exposure in moderate-to-severe Crohn's disease patients in Phase 2 induction and maintenance studies
    Mukherjee, A.
    Deng, C.
    Xie, R.
    Martin, S. W.
    Chan, G.
    Moscariello, M.
    Niezychowski, W.
    Maller, E.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S314 - S314
  • [19] Effectiveness and safety of subcutaneous infliximab in Crohn's disease patients with immunogenic failure of intravenous infliximab
    Husman, J.
    Cerna, K.
    Matthes, K.
    Gilger, M.
    Arsova, M.
    Schmidt, A.
    Winzer, N.
    Brosch, A. M.
    Hampe, J.
    Zeissig, S.
    Lukas, M.
    Schmelz, R.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1883 - I1884
  • [20] A PROSPECTIVE EVALUATION OF CLINICAL OUTCOMES OF SUBCUTANEOUS INFLIXIMAB FOLLOWING INTRAVENOUS INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE
    Kim, Min Kyu
    Lee, Cheol-Hyung
    Baek, Ji Eun
    Bae, June Hwa
    Park, Jung-Bin
    Hong, Seung Wook
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Ye, Byong Duk
    GASTROENTEROLOGY, 2024, 166 (05) : S830 - S830
12345